244
Participants
Start Date
May 30, 2018
Primary Completion Date
February 25, 2022
Study Completion Date
March 7, 2024
B/F/TAF
50/200/25 mg B/F/TAF FDC tablet administered orally once daily, without regard to food
Placebo to match DTG
Tablet administered orally once daily, without regard to food
Placebo to match F/TDF
Tablet administered orally once daily, without regard to food
DTG
50 mg tablet administered orally once daily, without regard to food
F/TDF
200/300 mg tablet administered orally once daily, without regard to food
Placebo to match B/F/TAF
Tablet administered orally once daily, without regard to food
National Taiwan University Hospital, Taipei
Instituto Dominicano de Estudios Virologicos (IDEV), Santo Domingo
Thai Red Cross AIDS Research Centre (HIV-NAT), Bangkok
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok
Hospital Pulau Pinang, Pulau Pinang
Evaggelismos General Hospital of Athens, Athens
Siriraj Hospital, Bangkok
Taipei City Hospital Linsen, Chinese Medicine and Kunming Branch, Taipei
Bamrasnaradura Infectious Diseases Institute, Nonthaburi
Taipei Veterans General Hospital, Taipei
Korgialenio-Benakio Greek Red Cross General Hospital, Athens
Laiko General Hospital, Athens
Hospital Raja Perempuan Zainab II, Kota Bharu
Hospital Sultanah Nur Zahirah, Kuala Terengganu
Far Eastern Memorial Hospital, New Taipei City
Fundacion Jimenez Diaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Raja Permaisuri Bainun, Ipoh
Ministry of Health and Welfare Taoyuan General Hospital, Taoyuan
Triple O Research Institute, P.A., West Palm Beach
Istanbul University Cerrahpasa Medical Faculty, Istanbul
Midway Immunology & Research, Ft. Pierce
CHUVI - Hospital Universitario Alvaro Cunqueiro, Vigo
Hospital de Canarias, Santa Cruz de Tenerife
Srinagarind Hospital, Khon Kaen
Taichung Veterans General Hospital, Taichung
Hospital General Universitario de Valencia, Valencia
Sungai Buloh Hospital, Sungai Buloh
Be Well Medical Center, Berkley
Pusan National University Hospital, Busan
Faculty of Medicine, Chiang Mai University, Chiang Mai
University Malaya Medical Centre, Kuala Lumpur
Hospital Kuala Lumpur, Kuala Lumpur
Chiang Rai Reginal Hospital, Chiang Rai
Hôpital de la Croix Rousse, Lyon
National Cheng Kung University Hospital, Tainan City
The Crofoot Research Center, INC (DBA: Gordon E. Crofoot MD PA), Houston
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Marmara University Pendik Training and Research Hospital, Istanbul
Kaohsiung Veterans General Hospital, Kaohsiung City
Queen Elizabeth Hospital, Kota Kinabalu
Sarawak General Hospital, Kuching
Beijing Ditan Hospital Capital Medical University, Beijing
Beijing YouAn Hospital, Capital Medical University, Beijing
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing
Shanghai Public Health Clinical Center, Shanghai
The First Hospital of Changsha, Changsha
Guangzhou Eighth people's Hospital, Guangzhou
Third People's Hospital Of Shenzhen, Shenzhen
Chengdu Public Health Clinical Center, Chengdu
1st Affiliated Hospital of Zhejiang University, Hangzhou
The Second Hospital of Nanjing, Nanjing
Prince of Wales Hospital, Hong Kong
Queen Elizabeth Hospital (QEH), Hong Kong
Princess Margaret Hospital, Kowloon
Hospital General Universitario Santa Lucia, Cartagena
AHEPA University Hospital of Thessaloniki, Thessaloniki
National Hospital Organization Nagoya Medical Center, Aichi
University of the Ryukyus Hospital, Okinawa
Osaka City General Hospital, Osaka
National Hospital Organization Osaka National Hospital, Osaka
The Jikei University Hospital, Tokyo
Juntendo University Hospital, Tokyo
Center Hospital of the National Center for Global Health and Medicine, Tokyo
Yokohama City University Hospital, Yokohama
Hope Clinical Research, San Juan
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Hospital Clinic de Barcelona, Barcelona
Lead Sponsor
Gilead Sciences
INDUSTRY